Syncom Formulations (India) Limited is a leading pharmaceutical company based in India. The company specializes in manufacturing and marketing a wide range of high-quality active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms.

With state-of-the-art facilities that adhere to international quality standards, Syncom Formulations has established itself as a reliable partner for global pharma companies by providing cost-effective products without compromising on quality.

The company's product portfolio includes APIs such as Metformin Hydrochloride, Losartan Potassium, Atorvastatin Calcium, and many more. In addition to APIs, they also offer various formulations including tablets, capsules, liquids, and ointments across different therapeutic segments like anti-diabetic drugs, cardiovascular agents, CNS agents & analgesics among others.

Syncom Formulations leverages innovative technology and robust research capabilities to develop new drug formulations while consistently improving the existing ones. Their commitment to innovation ensures that they stay ahead in the highly competitive pharmaceutical industry.

One key factor that sets Syncom Formulations apart from its competitors is its strong focus on compliance with regulatory requirements. The company strictly adheres to Good Manufacturing Practices (GMP) guidelines set by regulatory authorities like USFDA (United States Food & Drug Administration), EDQM (European Directorate for the Quality of Medicines), WHO-Geneva etc., ensuring that their products meet stringent quality standards globally.

In terms of collaboration and partnerships, Syncom Formulations has formed strategic alliances with several multinational pharmaceutical companies for contract manufacturing services which further enhances its reputation as a trusted player in the industry.